Hepatoblastoma risk factors: Difference between revisions
Jump to navigation
Jump to search
Nawal Muazam (talk | contribs) No edit summary |
Nawal Muazam (talk | contribs) No edit summary |
||
Line 17: | Line 17: | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Aicardi syndrome]]'''|| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Aicardi syndrome]]'''|| style="padding: 5px 5px; background: #F5F5F5;" | | ||
:* Agenesis of the corpus callosum, chorioretinal lacunae, and [[infantile spasms]], with a characteristic facies | :* Agenesis of the corpus callosum, chorioretinal lacunae, and [[infantile spasms]], with a characteristic facies | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Beckwith-Wiedemann syndrome]]'''|| style="padding: 5px 5px; background: #F5F5F5;"| | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Beckwith-Wiedemann syndrome]]'''|| style="padding: 5px 5px; background: #F5F5F5;"| | ||
:* [[Hemihypertrophy]], hemihyperplasia | :* [[Hemihypertrophy]], hemihyperplasia | ||
|- | |- | ||
Line 31: | Line 31: | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Glycogen storage diseases]] I–IV '''|| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Glycogen storage diseases]] I–IV '''|| style="padding: 5px 5px; background: #F5F5F5;" | | ||
:*Symptoms vary by individual disorder | :*Symptoms vary by individual disorder | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[low birth weight|Low birth weight infants]]'''|| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[low birth weight|Low birth weight infants]]'''|| style="padding: 5px 5px; background: #F5F5F5;" | | ||
:*Preterm and small-for-gestation-age neonates | :*Preterm and small-for-gestation-age neonates | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Simpson-Golabi-Behmel syndrome]]'''|| style="padding: 5px 5px; background: #F5F5F5;"| | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Simpson-Golabi-Behmel syndrome]]'''|| style="padding: 5px 5px; background: #F5F5F5;"| | ||
:*[[Macroglossia]], [[macrosomia]], renal and skeletal abnormalities, and increased risk of [[Wilms tumor]] | :*[[Macroglossia]], [[macrosomia]], renal and skeletal abnormalities, and increased risk of [[Wilms tumor]] | ||
|- | |- |
Revision as of 18:36, 16 November 2015
Hepatoblastoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hepatoblastoma risk factors On the Web |
American Roentgen Ray Society Images of Hepatoblastoma risk factors |
Risk calculators and risk factors for Hepatoblastoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]
Overview
Common risk factors in the development of hepatoblastoma are Aicardi syndrome, Beckwith-Wiedemann syndrome, familial adenomatous polyposis, low birth weight infants, and glycogen storage diseases.[1]
Risk Factors
The table below lists risk factors for hepatoblastoma:[1]
Associated Disorder | Clinical findings |
---|---|
Aicardi syndrome |
|
Beckwith-Wiedemann syndrome |
|
Familial adenomatous polyposis |
|
Glycogen storage diseases I–IV |
|
Low birth weight infants |
|
Simpson-Golabi-Behmel syndrome |
|
Trisomy 18, other trisomies |
|
References
- ↑ 1.0 1.1 Risk factors. National Cancer Institute 2015. http://www.cancer.gov/types/liver/hp/child-liver-treatment-pdq#link/_570_toc. Accessed on October 28, 2015